# Labomar Canada Inc – FDA Inspection, Nov 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/labomar-canada-inc/2e124ebe-7000-4a89-a941-b336a5a421f2
Source feed: FDA_Inspections

> FDA inspection 1073370 of Labomar Canada Inc, November 09, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073370
- Company Name: Labomar Canada Inc
- Inspection Date: 2018-11-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1249452 - 2024-08-09
- [FDA Inspection 998477 - 2016-12-15](https://www.keypedia.com/records/fda_inspections/labomar-canada-inc/a2c4d7cd-5439-45a1-a900-258d63499c8e)
- FDA Inspection 887471 - 2014-06-05
- FDA Inspection 763073 - 2011-12-02
- [FDA Inspection 605450 - 2009-08-13](https://www.keypedia.com/records/fda_inspections/labomar-canada-inc/dcb14cd4-103d-49f5-b2ac-a68706217264)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jessica-p-mcalister/d892c069-d283-4bb0-9cbb-78e463bfc1ea)

Company: https://www.keypedia.com/companies/labomar-canada-inc/1c212e6b-5d3d-4379-af67-cf8fde6c6aa4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c